| Product Code: ETC7539721 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market - Industry Life Cycle |
3.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market - Porter's Five Forces |
3.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.8 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing adoption of chemotherapy as a cancer treatment |
4.2.3 Rising awareness about managing side effects like nausea and vomiting |
4.3 Market Restraints |
4.3.1 High cost associated with chemotherapy induced nausea and vomiting drugs |
4.3.2 Limited reimbursement policies for these drugs in India |
4.3.3 Side effects and concerns regarding the efficacy of current drugs |
5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Trends |
6 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Types |
6.1 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Acute Emesis, 2021- 2031F |
6.1.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Delayed Emesis, 2021- 2031F |
6.1.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Anticipatory Emesis and Refractory Emesis, 2021- 2031F |
6.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Nk-1 Receptor Antagonist, 2021- 2031F |
6.2.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Serotonin Receptor Antagonist, 2021- 2031F |
6.2.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Population Type |
6.3.1 Overview and Analysis |
6.3.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Childrens, 2021- 2031F |
6.3.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Adults, 2021- 2031F |
6.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7 India Chemotherapy Induced Nausea and Vomiting Drugs Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Chemotherapy Induced Nausea and Vomiting Drugs Market Import-Export Trade Statistics |
7.1 India Chemotherapy Induced Nausea and Vomiting Drugs Market Export to Major Countries |
7.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Imports from Major Countries |
8 India Chemotherapy Induced Nausea and Vomiting Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed chemotherapy induced nausea and vomiting drugs |
8.2 Number of clinical trials and research studies on new drugs for managing side effects |
8.3 Adoption rate of antiemetic guidelines by healthcare providers |
9 India Chemotherapy Induced Nausea and Vomiting Drugs Market - Opportunity Assessment |
9.1 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.4 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 India Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Chemotherapy Induced Nausea and Vomiting Drugs Market - Competitive Landscape |
10.1 India Chemotherapy Induced Nausea and Vomiting Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Chemotherapy Induced Nausea and Vomiting Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here